1. Stacchiotti, S, Van Tine, BA. Synovial sarcoma: current concepts and future perspectives. J Clin Oncol. 2018;36(2):180‐187.
Google Scholar | Crossref | Medline2. Deshmukh, R, Mankin, HJ, Singer, S. Synovial sarcoma: the importance of size and location for survival. Clin Orthop Relat Res. 2004;419(419):155‐161.
Google Scholar | Crossref3. Balieiro, MA, Lopes, AJ, Costa, BP, et al. The surprising outcome of a giant primary mediastinal synovial sarcoma treated with neoadjuvant chemotherapy. J Thorac Dis. 2013;5(1):94‐96.
Google Scholar | Medline4. Xu, J, Wang, J, Cui, L, Wu, X. Malignant inguinal monophasic synovial sarcoma: report of a case and review of the literature. World J Surg Oncol. 2010;8(1):102.
Google Scholar | Crossref | Medline5. Hoang, NT, Acevedo, LA, Mann, MJ, Tolani, B. A review of soft-tissue sarcomas: translation of biological advances into treatment measures. Cancer Manag Res. 2018;2018(10):1089‐1114.
Google Scholar | Crossref | Medline6. Thway, K, Fisher, C. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol. 2014;18(6):369‐380.
Google Scholar | Crossref | Medline7. Bergh, P, Meis-Kindblom, JM, Gherlinzoni, F, et al. Synovial sarcoma: identification of low and high risk groups. Cancer. 1999;85(12):2596‐2607.
Google Scholar | Crossref | Medline8. Sandberg, AA, Bridge, JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. Cancer Genet Cytogenet. 2003;143(1):1‐31.
Google Scholar | Crossref | Medline9. Lagarde, P, Przybyl, J, Brulard, C, et al. Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas. J Clin Oncol. 2013;31(5):608‐615.
Google Scholar | Crossref | Medline10. Brennan, B, Stiller, C, Grimer, R, Dennis, N, Broggio, J, Francis, M. Outcome and the effect of age and socioeconomic status in 1318 patients with synovial sarcoma in the English national cancer registry: 1985-2009. Clin Sarcoma Res. 2016;6(1):18.
Google Scholar | Crossref | Medline11. Sultan, I, Rodriguez-Galindo, C, Saab, R, Yasir, S, Casanova, M, Ferrari, A. Comparing children and adults with synovial sarcoma in the surveillance, epidemiology, and end results program, 1983 to 2005: an analysis of 1268 patients. Cancer. 2009;115(15):3537‐3547.
Google Scholar | Crossref | Medline12. Vlenterie, M, Ho, VKY, Kaal, SEJ, Vlenterie, R, Haas, R, van der Graaf, WTA. Age as an independent prognostic factor for survival of localised synovial sarcoma patients. Br J Cancer. 2015;113(11):1602‐1606.
Google Scholar | Crossref | Medline13. Aytekin, MN, Öztürk, R, Amer, K, Yapar, A. Epidemiology, incidence, and survival of synovial sarcoma subtypes: SEER database analysis. J Orthop Surg (Hong Kong). 2020;28(2):2309499020936009.
Google Scholar | SAGE Journals | ISI14. Spillane, AJ, A’Hern, R, Judson, IR, Fisher, C, Thomas, JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol. 2000;18(22):3794‐3803.
Google Scholar | Crossref | Medline15. Lewis, JJ, Antonescu, CR, Leung, DH, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000;18(10):2087‐2094.
Google Scholar | Crossref | Medline16. Singer, S, Baldini, EH, Demetri, GD, Fletcher, JA, Corson, JM. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival. J Clin Oncol. 1996;14(4):1201‐1208.
Google Scholar | Crossref | Medline17. Bakri, A, Shinagare, AB, Krajewski, KM, et al. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J Roentgenol. 2012;199(2):W208‐W215.
Google Scholar | Crossref | Medline18. Al-Daraji, W, Lasota, J, Foss, R, Miettinen, M. Synovial sarcoma involving the head: analysis of 36 cases with predilection to the parotid and temporal regions. Am J Surg Pathol. 2009;33(10):1494‐1503.
Google Scholar | Crossref | Medline19. Krieg, AH, Hefti, F, Speth, BM, et al. Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol. 2011;22(2):458‐467.
Google Scholar | Crossref | Medline20. Yaser, S, Salah, S, Al-Shatti, M, et al. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients. Med Oncol. 2014;31(6):958.
Google Scholar | Crossref | Medline21. von Mehren, M, Randall, RL, Benjamin, RS, et al. Soft tissue sarcoma, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(5):536‐563.
Google Scholar | Crossref | Medline22. Song, S, Park, J, Kim, HJ, et al. Effects of adjuvant radiotherapy in patients with synovial sarcoma. Am J Clin Oncol. 2017;40(3):306‐311.
Google Scholar | Crossref | Medline23. Naing, KW, Monjazeb, AM, Li, CS, et al. Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: a SEER analysis. J Surg Oncol. 2015;111(2):158‐164.
Google Scholar | Crossref | Medline